UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D. C. 20460 OFFICE OF PREVENTION, PESTICIDES AND TOXIC SUBSTANCES Memorandum SUBJECT: EPA Clarifying Questions Regarding the USDA document " Economic Impact of the Chlorpyrifos methyl Phase out in U. S. Wheat Storage"

FROM: Bill Gross, Entomologist Herbicide and Insecticide Branch Tim Kiely, Economist Economic Analysis Branch Biological and Economic Analysis Division ( 7503C)

THRU: Arnet Jones, Chief Herbicide and Insecticide Branch David Widawsky, Chief Economic Analysis Branch Biological and Economic Analysis Division ( 7503C)

TO: Jackie Mosby Special Review and Reregistration Division ( 7508C)

The following is a list of clarifying economic and biological questions regarding the findings as reported in the USDA funded document titled " Economic Impact of the Chlorpyrifosmethyl Phase out in U. S. Wheat Storage".

Biological Questions The Chlorpyrifos methyl Economic Impact Report place a lot of emphasis on the dollar losses in stored wheat from insect infestations in the absence of chlorpyrifos methyl. We assume that your estimates are based on estimates of losses to the rice weevil, in that CPM does not control the lesser grain borer. Can you elaborate on this?

Let's assume that a grower stores his/ her wheat on farm, cleans the empty grain bin thoroughly of all residual stored grain insect pests before harvest, stores the wheat without the 2 application of a grain protectant, and the stored wheat has a low moisture content. What are the estimated losses that this grower could expect to incur at the grain elevator?

If Storicide were not available in its present form ( cyfluthrin and chlorpyrifos methyl) and the two products were registered separately as grain protectants, can you estimate the losses in stored wheat to lesser grain borer and rice weevil when these products are used alone?

We are aware that the lesser grain borer and rice weevil do co exist; however, it is common to find the rice weevil in greater numbers in the southern wheat production regions, and the lesser grain borer in the northern and plains wheat production regions. Assuming that good stored grain insect pests management practices are observed in all regions, can you estimate the expected losses at the grain elevators, based on pests presence in each respective region?

In the Efficacy and Cost Table of your Summary Report, you indicate that Spinosad is not effective against the weevils; however some literature do not support your claim. ( Liang Fang, Bhadriraju Subramanyam and Frank H. Arthur. Effectiveness of Spinosad on Four Classes of Wheat Against Five Stored Product Insects. Journal of Economic Entomology, 95( 3): 640 650 ( 2002).) In addition, efficacy data on Spinosad against stored product insect pests under an Experimental Use Permit is still being collected Economic Questions The estimated loss of $ 14.64 million without chlorpyrifos methyl available for use assumes that every bushel currently treated with chlorpyrifos methyl ( 183 million bushels) will receive a $ 0.10 discount in the absence of chlorpyrifos methyl ( less the cost of chlorpyrifos methyl, $ 0.02 per bushel).

A) What is the basis for the assumption that every bushel currently treated with chlorpyrifos methyl will receive the discount if chlorpyrifos methyl is no longer available for use on stored wheat? Page 20 of the assessment states that " Neither the presence nor the abundance of insect damage kernels was significantly associated with a greater risk of price discount, which appeared to indicate a tolerance of live insects and their damage on the part of many elevator managers". Why would you assume this would be different without chlorpyrifos methyl available for use? What proportion of the treated bushels receive the discount currently? Is there any evidence to suggest that the bushels currently treated with chlorpyrifos methyl would receive a different discount than if chlorpyrifosmethyl were not available for use, and users were applying either cyfluthrin or spinosad? Also, Table 8 suggests that no more than 30% ( and as little as 6%) of wheat growers receive a discount from elevator managers for insect damage.

B) What is the basis for the assumption of a $ 0.10 per bushel discount? Table 8 suggests discounts ranging from $ 0.02 per bushel to $ 0.08 per bushel. 3 C) What is the basis for the estimated cost per bushel of chemical insect control? The cost for each active ingredient listed was presented as a table during the presentation to US EPA.


Lydia Wegman/RTP/USEPA/US

05/01/2008 12:21 PM

To

"King, Heidi R."<EMAIL_ADDRESS> cc

Tricia Crabtree/RTP/USEPA/US@EPA, Karen Martin/RTP/USEPA/US@EPA, Mike Clark/DC/USEPA/US@EPA, Charlotte Bertrand/DC/USEPA/US@EPA, Zachary Pekar/RTP/USEPA/US@EPA, Robert Meyers/DC/USEPA/US@EPA, Jason Burnett/DC/USEPA/US@EPA

Subject

DOT edits--what we're going to do

Heidi,

We've looked at the edits from DOT and we can accept the last four.  The first change is inaccurate, so we won't make that change.  On the second edit, we'll leave the category as "mobile sources" and add a parenthetical "leaded aviation gas" to clarify the specific part of the category to which we refer.  These changes will not make it into this version but will be added and sent along in the next version.

 -----"King, Heidi R."<EMAIL_ADDRESS>wrote: -----

To: Lydia Wegman/RTP/USEPA/US@EPA

From: "King, Heidi R."<EMAIL_ADDRESS> Date: 05/01/2008 11:48AM

cc: Tricia Crabtree/RTP/USEPA/US@EPA, Karen Martin/RTP/USEPA/US@EPA, Mike Clark/DC/USEPA/US@EPA, Charlotte Bertrand/DC/USEPA/US@EPA, Zachary Pekar/RTP/USEPA/US@EPA, Robert Meyers/DC/USEPA/US@EPA, Jason Burnett/DC/USEPA/US@EPA

Subject: We'll discuss air-to-blood ratio further. DOT edits attached.

Thanks all for your time;  Attached are DOT requested edits

We’re further discussing ratio 1:7.

Best,

heidi

From<EMAIL_ADDRESS><EMAIL_ADDRESS>

Sent: Thursday, May 01, 2008 10:58 AM

To: King, Heidi R.

Cc: Beck, Nancy ; Lee, Amanda I. ; Fraas, Arthur G. ; <EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS>:PersonName; <EMAIL_ADDRESS><EMAIL_ADDRESS> Subject: RE: air-to-blood ratio section

Yes, 11:15 is fine.  Should I set up a call-in number so Jennifer and the RTP folks can tie-in?  Let's plan on using 4407 unless I hear otherwise from you.

-----"King, Heidi R."<EMAIL_ADDRESS>wrote: -----

To: Lydia Wegman/RTP/USEPA/US@EPA, " Beck, Nancy :PersonName" <EMAIL_ADDRESS>" Lee, Amanda I. "<EMAIL_ADDRESS>

From: "King, Heidi R."<EMAIL_ADDRESS> Date: 05/01/2008 10:34AM

cc: " Fraas, Arthur G. "<EMAIL_ADDRESS>Tricia Crabtree/RTP/USEPA/US@EPA, Karen Martin/RTP/USEPA/US@EPA, Robert Meyers/DC/USEPA/US@EPA, Jason Burnett/DC/USEPA/US@EPA, Mike Clark/DC/USEPA/US@EPA, Charlotte Bertrand/DC/USEPA/US@EPA, Zachary Pekar/RTP/USEPA/US@EPA

Subject: RE: air-to-blood ratio section

Lydia et al,

How about a short 11:15 am conversation, agenda items below.  Could Zack pls invite Jennifer Seed from OPPTS?  Maria Doa is on travel, but it sounds like Jennifer is available at that time. Perhaps Mike and Charlotte to reach out to Fred, the OPPTS OPEI lead, as appropriate.

Agenda items:

       Lead RRP rule baseline issue (should be quick)

       Tables:  Agreed upon edits in Tbl 1 are not reflected in the version we rec’d this morning; Tbl 6 looks good

       Dept of Transportation comments – how to resolve

       Ratios

       Timing of next draft for review preamble

       RIA review status

Thanks,

heidi

From<EMAIL_ADDRESS><EMAIL_ADDRESS>

Sent: Thursday, May 01, 2008 8:42 AM

To: King, Heidi R.

Cc: Fraas, Arthur G<EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS> Subject: RE: air-to-blood ratio section

We have talked to Jennifer Seed and Maria Doa at OPPTS.  They agree with the footnote as written.  They are available to talk with you and us at any time.  When would you like to talk?

-----"King, Heidi R."<EMAIL_ADDRESS>wrote: -----

To: Lydia Wegman/RTP/USEPA/US@EPA, " Fraas, Arthur G. :PersonName" <EMAIL_ADDRESS> From: "King, Heidi R."<EMAIL_ADDRESS> Date: 05/01/2008 07:33AM

cc: Tricia Crabtree/RTP/USEPA/US@EPA, Karen Martin/RTP/USEPA/US@EPA, Robert Meyers/DC/USEPA/US@EPA, Jason Burnett/DC/USEPA/US@EPA

Subject: RE: air-to-blood ratio section

I haven’t heard from OPPTS yet on the LRRP rule language; I’ll keep trying, but if someone else has made contact pls let me know.

Thank you,

heidi

From<EMAIL_ADDRESS><EMAIL_ADDRESS>

Sent: Thursday, May 01, 2008 12:46 AM

To: King, Heidi R.; Fraas, Arthur G. :PersonName :PersonName :PersonName

Cc<EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS> Subject: Re: air-to-blood ratio section

We'll plan to discuss this later this morning.

 ----- Original Message -----

  From: "King, Heidi R."<EMAIL_ADDRESS>   Sent: 05/01/2008 12:16 AM AST

  To: Lydia Wegman; " Fraas, Arthur G. :PersonName :PersonName :PersonName"<EMAIL_ADDRESS>   Cc: Tricia Crabtree; Karen Martin; Robert Meyers; Jason Burnett

  Subject: RE: air-to-blood ratio section

Lydia ,

Thank you for this draft.  Two comments:

1.  We failed to note additional or clarified support for the higher ratios.  We remain somewhat uncomfortable with characterizing the science-based support for a ratio of 1:7 as equivalently robust to the science-based support for standards ranging up to 1:6.  I believe we’ll pick up the conversation in the morning.

2.  Questions regarding “reanalysis” and “potentially” on p 4:

More recently, a study of changes in children’s blood Pb levels associated with reduced Pb emissions and associated air concentrations near a Pb smelter in Canada (for children through age six in age) reports a ratio of 1:6 and reanalysis << Did the Agency mean to say additional analysis ??  Our conversation had not left me with the impression that the Hilts dataset has been reanalyzed by the Agency >> of the data by EPA for the initial time period of the study resulted in a ratio of 1:7 (CD, pp. 3-23 to 3-24; Hilts, 2003). [1]   Ambient air and blood Pb levels associated with the Hilts (2003) study range from 1.1 to 0.03 µg/m 3 , and associated population mean blood Pb levels range from 11.5 to 4.7 µg/dL, which are lower than levels associated with the older studies cited in the 1986 Criteria Document (USEPA, 1986).

Sources of uncertainty potentially  << The sentence reads well without “potentially”.  I believe these uncertainties are not potentially related; they were identified by the author as related >> related to air-to-blood ratios obtained from Hilts (2003) study have been identified.

Best regards,

heidi

From<EMAIL_ADDRESS><EMAIL_ADDRESS>

Sent: Wednesday, April 30, 2008 11:25 PM

To: King, Heidi R.; Fraas, Arthur G. :PersonName :PersonName :PersonName

Cc<EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS><EMAIL_ADDRESS> Subject: Fw: air-to-blood ratio section

-----Forwarded by Lydia Wegman/RTP/USEPA/US on 04/30/2008 11:24PM -----

To: Wegman Lydia@EPA

From: Karen Martin/RTP/USEPA/US

Date: 04/30/2008 10:28PM

Subject: air-to-blood ratio section

Karen Martin, Ph.D.

Office of Air Quality Planning and Standards

U.S. EPA (C504-06)

Research Triangle Park , NC 27711

phone:<PHONE_NUMBER>

fax:<PHONE_NUMBER>

<EMAIL_ADDRESS>

]

n

t

·

¾

Þ

ã

ò

÷

㜀$␸䠀$葝ᚠ葞ᆘ摧罠xఀ

²

Ë

2

4

Y

[

b

d

k

m

n

¸

ß

ó

for children in the area over the full period was approximately 1:6. The author noted limitations in the dataset associated with exposures in the second time period, after the temporary shutdown of the facility in 2001, including sampling of a different age group at that time and a shorter time period (3 months) at these lower ambient air Pb levels prior to collection of blood Pb levels. Consequently, EPA calculated an alternate air-to-blood Pb ratio based on consideration for ambient air Pb and blood Pb reductions in the first time period (after opening of the new facility in 1997).


[Federal Register: February 10, 2006 (Volume 71, Number 28)]
[Notices]
[Page 7024]
[DOCID:fr10fe06-50]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP06-196-000]

National Fuel Gas Supply Corporation; Notice of Tariff Filing

February 3, 2006.
    Take notice that on January 31, 2006, National Fuel Gas Supply
Corporation (National) tendered for filing as part of its FERC Gas
Tariff, Fourth Revised Volume No. 1, Eighty Sixth Revised Sheet No. 9,
to become effective February 1, 2006.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed in accordance with the provisions of
Sec.  154.210 of the Commission's regulations (18 CFR 154.210). Anyone
filing an intervention or protest must serve a copy of that document on
the Applicant. Anyone filing an intervention or protest on or before
the intervention or protest date need not serve motions to intervene or
protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive email
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please email
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
 [FR Doc. E6-1862 Filed 2-9-06; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register: September 18, 2006 (Volume 71, Number 180)]
[Notices]
[Page 54649-54650]
[DOCID:fr18se06-63]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Notice of Application for Transfer of License and Soliciting
Comments, Motions To Intervene, and Protests

September 8, 2006.
    Take notice that the following hydroelectric application has been
filed with the Commission and is available for public inspection:
    a. Application Type: Transfer of License.
    b. Project No.: 2902-019.
    c. Date Filed: August 28, 2006.
    d. Applicants: Nekoosa Packaging Corporation (NPC) and GP Big
Island, LLC (GP Big Island).
    e. Name and Location of Project: The Big Island Project is located
on the James River, near the Town of Big Island and the City of
Lynchburg, in Amherst and Bedford Counties, Virginia.
    f. Filed Pursuant to: Federal Power Act, 16 U.S.C. 791(a)-825(r).
    g. Applicant Contacts: For NPC and GP Big Island: Mr. Richard C.
Judy, Nekoosa Packaging Corporation, 9363 Lee Jackson Highway, Big
Island, VA 24526,<PHONE_NUMBER>. Mr. Matthew D. Manahan, Pierce Atwood
LLP, One Monument Square, Portland, ME 04101,<PHONE_NUMBER>.
    h. FERC Contact: Etta L. Foster<PHONE_NUMBER>.
    i. Deadline for filing comments, protests, and motions to
intervene: September 29, 2006.
    All documents (original and eight copies) should be filed with
Magalie R. Salas, Secretary, Federal Energy Regulatory Commission, 888
First Street, NE., Washington, DC 20426. Comments, protests, and
interventions may be filed electronically via the Internet in lieu of
paper, see 18 CFR 385.2001(a)(1)(iii) and the instructions on the
Commission's Web site under the ``e-Filing'' link. The Commission
strongly encourages electronic filings. Please include the project
number (P-2902-019) on any comments, protests, or motions filed. The
Commission's Rules of Practice and Procedure require all interveners
filing a document with the Commission to serve a copy of that document
on each person in the official service list for the project. Further,
if an

intervener files comments or documents with the Commission relating to
the merits of an issue that may affect the responsibilities of a
particular resource agency, they must also serve a copy of the
documents on that resource agency.
    j. Description of Application: Applicants request approval, under
Section 8 of the Federal Power Act, of a transfer of license for the
Big Island Project No. 2902 from the Nekoosa Packaging Corporation to
GP Big Island, LLC.
    k. This filing is available for review at the Commission in the
Public Reference Room or may be viewed on the Commission's Web site at
http://www.ferc.gov using the ``FERRIS'' link. Enter the project number

excluding the last three digits (P-8315) in the docket number field to
access the document. For online assistance, contact
<EMAIL_ADDRESS>or call toll-free<PHONE_NUMBER>, for TTY,

call<PHONE_NUMBER>. A copy is also available for inspection and
reproduction at the addresses in item g.
    l. Individual desiring to be included on the Commission's mailing
list should so indicate by writing to the Secretary of the Commission.
    m. Comments, Protests, or Motions to Intervene--Anyone may submit
comments, a protest, or a motion to intervene in accordance with the
requirements of Rules of Practice and Procedure, 18 CFR 385.210, .211,
.214. In determining the appropriate action to take, the Commission
will consider all protests or other comments filed, but only those who
file a motion to intervene in accordance with the Commission's Rules
may become a party to the proceeding. Any comments, protests, or
motions to intervene must be received on or before the specified
comment date for the particular application.
    n. Filing and Service of Responsive Documents--Any filings must
bear in all capital letters the title ``Comments'', ``Protests'', or
``Motion to Intervene'', as applicable, and the Project Number of the
particular application to which the filing refers. Any of the above-
named documents must be filed by providing the original and the number
of copies provided by the Commission's regulations to: The Secretary,
Federal Energy Regulatory Commission, 888 First Street, NE.,
Washington, DC 20426. A copy of any motion to intervene must also be
served upon each representative of the Applicant specified in the
particular application.
    o. Agency Comments--Federal, state, and local agencies are invited
to file comments on the described application. A copy of the
application may be obtained by agencies directly from the Applicant. If
an agency does not file comments within the time specified for filling
comments, it will be assumed to have no comments. One copy of an
agency's comments must also be sent to the Applicant's representatives.

Magalie R. Salas,
Secretary.
[FR Doc. E6-15375 Filed 9-15-06; 8:45 am]

BILLING CODE 6717-01-P


  HYPERLINK
"http://www.state.nj.us/dep/baqp/8hrsip/Appendices-Attachments/G%20for%2
0Fleet%20Turnover%20Benefit%20Calculations.zip"  Appendix D10  Att –
Supplemental CMAQ Model Performance and Assessment 8-HR OTC Ozone
Modeling (zip file)

ZIP file contains 16 files.

For copies of files access the New Jersey Department of Environmental
Protection web site:

  HYPERLINK "http://www.state.nj.us/dep/baqp/8hrsip/8hrsip.html#final"
http://www.state.nj.us/dep/baqp/8hrsip/8hrsip.html#final


[Federal Register: October 6, 2005 (Volume 70, Number 193)]
[Notices]
[Page 58406]
[DOCID:fr06oc05-80]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 2071-013--Washington, Project No. 2111-018--Washington,
Project No. 935-053--Washington, Project No. 2071-013--Washington]

Lewis River Projects: PacifiCorp and Cowlitz PUD; Notice of
Intention To Hold Public Meetings To Discuss the Draft Environmental
Impact Statement for the Lewis River Hydropower Projects

September 28, 2005.

    On September 16, 2005, the Commission staff mailed the Lewis River
Projects Draft Environmental Impact Statement (DEIS) to the
Environmental Protection Agency, resource and land management agencies,
and interested organizations and individuals.
    Notice of the DEIS was published in the Federal Register on
September 23, 2005, and comments are due November 23, 2005. The DEIS
evaluates the environmental consequences of the construction,
operation, and maintenance of the Lewis River Projects in Washington.
The DEIS also evaluates the environmental effects of implementing the
applicant's proposals, agency and NGO recommendations, staff's
modifications, and the no-action alternative.
    A public meeting is scheduled for Thursday, October 27, 2005, from
10 a.m. to 3 p.m. (PST) at the Oak Tree Restaurant, 1020 Atlantic
Avenue, Woodland, WA 98674.
    At this meeting, resource agency personnel and other interested
persons will have the opportunity to provide oral and written comments
and recommendations regarding the DEIS for the Commission's public
record. These meetings will be recorded by an official stenographer.
    For further information, please contact Ann-Ariel Vecchio at (202)
502-6351, or by e-mail at<EMAIL_ADDRESS>
Magalie R. Salas,
Secretary.
[FR Doc. E5-5510 Filed 10-5-05; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 76, Number 230 (Wednesday, November 30, 2011)]
[Notices]
[Pages 74111-74113]
[FR Doc No: 2011-30819]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-65824; File No. SR-CBOE-2011-111]

Self-Regulatory Organizations; Chicago Board Options Exchange,
Incorporated; Notice of Filing and Immediate Effectiveness of Proposed
Rule Change Related to the Individual Stock Trading Pause Pilot Program

November 23, 2011.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(the ``Act''),\1\ and Rule 19b-4 thereunder,\2\ notice is hereby given
that on November 23, 2011, the Chicago Board Options Exchange,
Incorporated (``Exchange'' or ``CBOE'') filed with the Securities and
Exchange Commission (the ``Commission'') the proposed rule change as
described in Items I and II below, which Items have been prepared by
the Exchange. The Exchange has designated the proposal as a ``non-
controversial'' proposed rule change pursuant to Section
19(b)(3)(A)(iii) of the Act \3\ and Rule 19b-4(f)(6) thereunder.\4\ The
Commission is publishing this notice to solicit comments on the
proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
    \3\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \4\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange is proposing to amend CBOE Stock Exchange, LLC's
(``CBSX'', the CBOE's stock trading facility) rules to exclude all
rights and warrants from the individual stock trading pause pilot and
to include a conforming amendment to CBOE's options trading halt
provisions. The text of the proposed rule change is available on the
Exchange's Web site (http://www.cboe.org/Legal), at the Exchange's
Office of the Secretary and at the Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule change and
discussed any comments it received on the proposed rule change. The
text of those statements may be examined at the places specified in
Item IV below. The Exchange has prepared summaries, set forth in
sections A, B, and C below, of the most significant parts of such
statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to amend Rule 6.3C to exclude all rights and
warrants from the single stock circuit breaker under the rule. The
Commission approved Rule 6.3C on a pilot basis on June 10, 2010 to
provide for trading pauses in individual securities due to
extraordinary market volatility (``Trading Pause'') in all securities
included within the S&P 500 [supreg] Index (``S&P 500'') (``Pause
Pilot'').\5\ The Exchange subsequently received approval to add to the
Pause Pilot the securities included in the Russell 1000[supreg] Index
(``Russell 1000'') and a specified list of Exchange Traded Products
(``ETPs'').\6\
---------------------------------------------------------------------------

    \5\ The Commission approved the Pause Pilot for all equities
exchanges and FINRA. See Securities Exchange Act Release No. 62252
(June 10, 2010), 75 FR 34186 (June 16, 2010) (File Nos. SR-BATS-
2010-014; SR-EDGA-2010-01; SR-EDGX-2010-01; SR-BX-2010-037; SR-ISE-
2010-48; SR-NYSE-2010-39; SR-NYSEAmex-2010-46; SR-NYSEArca-2010-41;
SR-NASDAQ-2010-061; SR-CHX-2010-10; SR-NSX-2010-05; and SR-CBOE-
2010-047) and Securities Exchange Act Release No. 62251 (June 10,
2010), 75 FR 34183 (June 16, 2010) (SR-FINRA-2010-025).
    \6\ The Commission approved the addition to the Pause Pilot of
the securities included in the Russell 1000 and ETPs, where
applicable, for all equities exchanges and FINRA See Securities
Exchange Act Release No. 62884 (September 10, 2010), 75 FR 56618
(September 16, 2010) (File Nos. SR-BATS-2010-018; SR-BX-2010-044;
SR-CBOE-2010-065; SR-CHX-2010-14; SR-EDGA-2010-05; SR-EDGX-2010-05;
SR-ISE-2010-66; SR-NASDAQ-2010-079; SR-NYSE-2010-49; SR-NYSEAmex-
2010-63; SR-NYSEArca-2010-61; and SR-NSX-2010-08 and Securities
Exchange Act Release No. 62883 (September 10, 2010), 75 FR 56608
(September 16, 2010) (SR-FINRA-2010-033). The Pause Pilot, which was
originally set to expire on December 10, 2010, has been extended and
is currently set to expire on January 31, 2012. See Securities
Exchange Act Release Nos. 63502 (December 9, 2010), 75 FR 78306
(December 15, 2010) (SR-CBOE-2010-112) (extension of Pilot through
April 11, 2011); 64194 (April 5, 2011), 76 FR 20389 (April 12,
2011)(SR-CBOE-2011-031)(extension of Pilot through the earlier of
August 11, 2011 or the date on which a limit up-limit down mechanism
to address extraordinary market volatility, if adopted, applies to
the pilot stocks) and 65070 (August 9, 2011), 76 FR 50516 (August
15, 2011)(SR-CBOE-2011-076).
---------------------------------------------------------------------------

    On June 23, 2011, the Commission approved proposed rule changes to
expand the Pause Pilot to include all remaining NMS stocks (``Phase III
Securities''), which included rights and warrants.\7\ Unlike the
original Pause Pilot securities, amended Rule 6.3C applies wider
percentage price moves to the Phase III Securities before a trading
pause is triggered.\8\ The changes to Rule 6.3C became effective on
August 8, 2011.\9\
---------------------------------------------------------------------------

    \7\ See Securities Exchange Act Release No. 64735 (June 23,
2011), 76 FR 38243 (June 29, 2011) (SR-NASDAQ-2011-067, et al.).
    \8\ Under amended Rule 6.3C, a pause is triggered by a 30% or
more price move in a Phase III Security priced at $1 or higher, and
by a 50% or more price move to such a security priced less than $1.
The price of a security is based on the closing price on the
previous trading day, or, if no closing price exists, the last sale
reported to the Consolidated Tape on the previous trading day.
    \9\ The Exchange notes that CBSX is not currently the primary
listing market for any stocks, and thus, will not be issuing any
trading pauses pursuant to its rules.
---------------------------------------------------------------------------

    Analysis of the nature of the trading pauses triggered since
adoption of the Pause Pilot notes that over 25% of such pauses have
occurred in rights and warrants. Further, there has been a significant
increase in trading pauses involving rights and warrants since the
implementation of the Phase III Securities, with such pauses
representing approximately 52% [sic] all trading pauses occurring
through the end of August 2011. Rights and warrants trade on equity
exchanges, but are closely related to call options. Rights and warrants
entitle owners to purchase shares of stock at predetermined prices
subject to various timing and other conditions. Like options, the price
of rights and warrants are affected by the price of the underlying
stock as well as other factors, particularly the volatility of the
stock. As a consequence, the prices of rights and warrants may move
more dramatically than the prices of the underlying stocks even when
the rights and warrants (and the underlying stock) are trading in an
orderly manner. This difference in trading behavior may result in a
scenario whereby the rights and warrants trigger the circuit breaker
under Rule 6.3C and are subject to a trading pause, even while the
underlying stock continues to trade. This can be particularly true of
rights and warrants that have low prices. Accordingly, the Exchange is
proposing to exclude rights and warrants from the trading pause under
Rule 6.3C.

    Finally, the Exchange is proposing a conforming amendment to Rule
6.3.06, which pertains to trading halts on CBOE. In relevant part, Rule
6.3.06 currently provides that, if the primary listing market issues an
individual stock trading pause in an underlying NMS stock, then CBOE
will halt trading in the options on that stock until trading has
resumed in the stock. Given the proposed exclusion of rights and
warrants from the Pause Pilot, the Exchange is proposing to replace a
reference in Rule 6.2.06 to ``an underlying NMS stock'' with a
conforming reference to ``an underlying eligible NMS stock'' and to
define the term ``eligible NMS stocks'' to mean NMS stocks, other than
rights and warrants.
2. Statutory Basis
    The proposed rule change is consistent with Section 6(b) of the
Act,\10\ in general, and furthers the objectives of Section
6(b)(5),\11\ in particular, in that it is designed to prevent
fraudulent and manipulative acts and practices, to promote just and
equitable principles of trade, to foster cooperation and coordination
with persons engaged in facilitating transactions in securities, and to
remove impediments to and perfect the mechanism of a free and open
market and a national market system. The proposed rule change also is
designed to support the principles of Section 11A(a)(1) \12\ of the Act
in that it seeks to ensure fair competition among brokers and dealers
and among exchange markets. The Exchange believes that the proposed
rule meets these requirements because it excludes certain securities
from Rule 6.3C's coverage that are prone to triggering pauses because
of their unique characteristics. These securities are unique in that
they may move more dramatically than the prices of the underlying
stocks to which they are related even when both securities are trading
in an orderly manner. As such, the securities that are subject to this
proposal may trigger the circuit breaker under Rule 6.3C and be subject
to a trading pause, even while the underlying security continues to
trade. Although there is little benefit in pausing trading in these
securities, such pauses sequester regulatory resources that are better
applied to the review of trading pauses in other securities that have a
greater impact on the national market system.
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78f(b).
    \11\ 15 U.S.C. 78f(b)(5).
    \12\ 15 U.S.C. 78k-1(a)(1).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    The Exchange neither solicited nor received comments on the
proposal.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The Exchange has filed the proposed rule change pursuant to Section
19(b)(3)(A)(iii) of the Act \13\ and Rule 19b-4(f)(6) thereunder.\14\
Because the proposed rule change does not: (i) Significantly affect the
protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative prior to
30 days from the date on which it was filed, or such shorter time as
the Commission may designate, if consistent with the protection of
investors and the public interest, the proposed rule change has become
effective pursuant to Section 19(b)(3)(A) of the Act \15\ and Rule 19b-
4(f)(6)(iii) thereunder.\16\
---------------------------------------------------------------------------

    \13\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \14\ 17 CFR 240.19b-4(f)(6).
    \15\ 15 U.S.C. 78s(b)(3)(A).
    \16\ 17 CFR 240.19b-4(f)(6). In addition, Rule 19b-4(f)(6)(iii)
requires the Exchange to give the Commission written notice of the
Exchange's intent to file the proposed rule change along with a
brief description and text of the proposed rule change, at least
five business days prior to the date of filing of the proposed rule
change, or such shorter time as designated by the Commission. The
Exchange has satisfied this requirement.
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) \17\ normally
does not become operative for 30 days after the date of filing.
However, pursuant to Rule 19b-4(f)(6)(iii) \18\ the Commission may
designate a shorter time if such action is consistent with the
protection of investors and the public interest. The Exchange has asked
the Commission to waive the 30-day operative delay so that the proposal
may become operative immediately upon filing.
---------------------------------------------------------------------------

    \17\ 17 CFR 240.19b-4(f)(6).
    \18\ 17 CFR 240.19b-4(f)(6)(iii).
---------------------------------------------------------------------------

    The Commission believes that waiving the 30-day operative delay is
consistent with the protection of investors and the public interest.
Including rights and warrants in the pilot program which may trigger a
circuit breaker and be subject to a trading pause, even while the
underlying security continues to trade, provides little benefit and has
the potential to create confusion among investors. Excluding rights and
warrants from the pilot program should minimize investor confusion that
could result from temporary trading pauses in these securities. For
this reason, the Commission designates the proposed rule change as
operative upon the date of this Notice.\19\
---------------------------------------------------------------------------

    \19\ For purposes only of waiving the 30-day operative delay,
the Commission has also considered the proposed rule's impact on
efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File No. SR-CBOE-2011-111 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street NE.,
Washington, DC 20549-1090.

All submissions should refer to File No. SR-CBOE-2011-111. This file
number should be included on the subject line if email is used. To help
the Commission process and review your comments more efficiently,
please use only one method. The Commission will post all comments on
the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments, all
written statements with respect to the proposed rule change that are
filed with the Commission, and all written communications relating to
the proposed rule change between the Commission and any person, other
than those that may be withheld from the

public in accordance with the provisions of 5 U.S.C. 552, will be
available for Web site viewing and printing in the Commission's Public
Reference Room, 100 F Street NE., Washington, DC 20549, on official
business days between the hours of 10 a.m. and 3 p.m. Copies of such
filing also will be available for inspection and copying at the
principal office of the Exchange. All comments received will be posted
without change; the Commission does not edit personal identifying
information from submissions. You should submit only information that
you wish to make available publicly. All submissions should refer to
File No. SR-CBOE-2011-111 and should be submitted on or before December
21, 2011.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\20\
---------------------------------------------------------------------------

    \20\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2011-30819 Filed 11-29-11; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 77, Number 114 (Wednesday, June 13, 2012)]
[Notices]
[Page 35376]
[FR Doc No: 2012-14350]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER12-1923-000]

Big Savage, LLC; Supplemental Notice That Initial Market-Based
Rate Filing Includes Request for Blanket Section 204 Authorization

    This is a supplemental notice in the above-referenced proceeding of
Big Savage, LLC's application for market-based rate authority, with an
accompanying rate tariff, noting that such application includes a
request for blanket authorization, under 18 CFR part 34, of future
issuances of securities and assumptions of liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is June 27, 2012.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street, NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive email notification
when a document is added to a subscribed docket(s). For assistance with
any FERC Online service, please email<EMAIL_ADDRESS>or
call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

    Dated: June 7, 2012.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2012-14350 Filed 6-12-12; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 76, Number 153 (Tuesday, August 9, 2011)]
[Notices]
[Pages 48842-48843]
[FR Doc No: 2011-20041]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 13005-001]

Oliver Hydro LLC; Notice of Intent To File License Application,
Filing of Pre-Application Document, and Approving Use of the
Traditional Licensing Process

    a. Type of Filing: Notice of Intent to File License Application and
Request to Use the Traditional Licensing Process.
    b. Project No.: 13005-001.
    c. Dated Filed: May 20, 2011.
    d. Submitted by: Symbiotics LLC, on behalf of Oliver Hydro LLC.
    e. Name of Project: William Bacon Oliver Lock and Dam Hydroelectric
Project.
    f. Location: At the U.S. Army Corps of Engineers' (Corps) William
Bacon Oliver Lock and Dam on the Black Warrior River, in Tuscaloosa
County, Alabama. The project would occupy 26.9 acres of United States
lands administered by the Corps' Mobile District.
    g. Filed Pursuant to: 18 CFR 5.3 of the Commission's regulations.
    h. Potential Applicant Contact: Brent Smith, Symbiotics LLC, 371
Upper Terrace, Suite 2, Bend, OR 97702;<PHONE_NUMBER>; or e-mail
<EMAIL_ADDRESS>    i. FERC Contact: Rachel McNamara at<PHONE_NUMBER>; or e-mail at
<EMAIL_ADDRESS>    j. Symbiotics LLC, on behalf of Oliver Hydro LLC, filed its request
to use the Traditional Licensing Process on May 20, 2011. Symbiotics
LLC provided public notice of its request on May 23, 2011. In a letter
dated July 20, 2011, the Director of the Division of Hydropower
Licensing approved Symbiotics LLC's request to use the Traditional
Licensing Process.
    k. With this notice, we are initiating informal consultation with:
(a) The U.S. Fish and Wildlife Service under section 7 of the
Endangered Species Act and the joint agency regulations thereunder at
50 CFR, part 402 and (b) the Alabama State Historic Preservation
Officer, as required by section 106, National Historical Preservation
Act, and the implementing regulations of the Advisory Council on
Historic Preservation at 36 CFR 800.2.

    l. Symbiotics LLC, on behalf of Oliver Hydro LLC, filed a Pre-
Application Document (PAD; including a proposed process plan and
schedule) with the Commission, pursuant to 18 CFR 5.6 of the
Commission's regulations.
    m. A copy of the PAD is available for review at the Commission in
the Public Reference Room or may be viewed on the Commission's Web site
(http://www.ferc.gov), using the ``eLibrary'' link. Enter the docket
number, excluding the last three digits in the docket number field to
access the document. For assistance, contact FERC Online Support at
<EMAIL_ADDRESS>or toll free at 1-866-208-3676, or for TTY,
(202) 502-8659. A copy is also available for inspection and
reproduction at the address in paragraph h.
    n. Register online at http://www.ferc.gov/docs-filing/esubscription.asp to be notified via e-mail of new filing and issuances
related to this or other pending projects. For assistance, contact FERC
Online Support.

    Dated: July 29, 2011.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2011-20041 Filed 8-8-11; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 84, Number 31 (Thursday, February 14, 2019)]
[Notices]
[Pages 4063-4066]
[FR Doc No: 2019-02385]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2018-0014; FRL-9987-92]

Product Cancellation Order for Certain Pesticide Registrations
and Amendments To Terminate Uses

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice announces EPA's order for the cancellations and
amendments to terminate uses, voluntarily requested by the registrants
and accepted by the Agency, of the products listed in Table 1 and Table
2 of Unit II, pursuant to the Federal Insecticide, Fungicide, and
Rodenticide Act (FIFRA). This cancellation order follows an October 17,
2018 Federal Register Notice of Receipt of Requests from the
registrants listed in Table 3 of Unit II to voluntarily cancel and
amend to terminate uses of these product registrations. In the October
17, 2018 notice, EPA indicated that it would issue an order
implementing the cancellations and amendments to terminate uses, unless
the Agency received substantive comments within the 30-day comment
period that would merit its further review of these requests, or unless
the registrants withdrew their requests. The Agency did not receive any
comments on the notice. Further, the registrants did not withdraw their
requests. Accordingly, EPA hereby issues in this notice a cancellation
order granting the requested cancellations and amendments to terminate
uses. Any distribution, sale, or use of the products subject to this
cancellation order is permitted only in accordance with the terms of
this order, including any existing stocks provisions.

DATES: The cancellations and amendments are effective February 14,
2019.

FOR FURTHER INFORMATION CONTACT: Christopher Green, Information
Technology and Resources Management Division (7502P), Office of
Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460-0001; telephone number:<PHONE_NUMBER>;
email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    This action is directed to the public in general, and may be of
interest to a wide range of stakeholders including environmental, human
health, and agricultural advocates; the chemical industry; pesticide
users; and members of the public interested in the sale, distribution,
or use of pesticides. Since others also may be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action.

B. How can I get copies of this document and other related information?

    The docket for this action, identified by docket identification
(ID) number EPA-HQ-OPP-2018-0014, is available at http://www.regulations.gov or at the Office of Pesticide Programs Regulatory
Public Docket (OPP Docket) in the Environmental Protection Agency
Docket Center (EPA/DC), West William Jefferson Clinton Bldg., Rm. 3334,
1301 Constitution Ave. NW, Washington, DC 20460-0001. The Public
Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through
Friday, excluding legal holidays. The telephone number for the Public
Reading Room is<PHONE_NUMBER>, and the telephone number for the OPP
Docket is<PHONE_NUMBER>. Please review the visitor instructions and
additional information about the docket available at http://www.epa.gov/dockets.

II. What action is the agency taking?

    This notice announces the cancellations and amendments to terminate
uses, as requested by registrants, of products registered under FIFRA
section 3 (7 U.S.C. 136a). These registrations are listed in sequence
by registration number in Tables 1 and 2 of this unit.

                                         Table 1--Product Cancellations
----------------------------------------------------------------------------------------------------------------
           Registration No.              Company No.           Product name               Active ingredients
----------------------------------------------------------------------------------------------------------------
100-974..............................             100  Platinum Ridomil Gold.......  Thiamethoxam & Metalaxyl-M.
100-1149.............................             100  CGA-329351 138 ES...........  Metalaxyl-M.
100-1184.............................             100  Cruiser XL Insecticide and    Metalaxyl-M; Fludioxonil &
                                                        Fungicide Prepack.            Thiamethoxam.
100-1208.............................             100  Cruiser Extreme.............  Azoxystrobin; Metalaxyl-M;
                                                                                Fludioxonil &
                                                                                Thiamethoxam.
100-1284.............................             100  Dynasty Extreme.............  Myclobutanil; Metalaxyl-M;
                                                                                Fludioxonil &
                                                                                Azoxystrobin.
100-1335.............................             100  Difenoconazole/Mefenoxam FS.  Difenoconazole & Metalaxyl-
                                                                                M.
100-1413.............................             100  Ariel.......................  Metalaxyl-M.
352-754..............................             352  Dupont Imazapyr 75XP          Imazapyr.
                                                        Herbicide.
432-1578.............................             432  Lineage Clearstand..........  Metsulfuron & Imazapyr.
499-373..............................             499  Whitmire PT 289 Orthense....  Acephate.
1381-226.............................            1381  Imidacloprid 60% WSP ORN      Imidacloprid.
                                                        Insecticide.
2217-759.............................            2217  Embark 2-S Plant Growth       Mefluidide, diethanolamine
                                                        Regulator.                    salt.
2217-766.............................            2217  Embark 2-L Plant Growth       N-(2,4-Dimethyl-5-
                                                        Regulator.                    (((trifluoromethyl)sulfony
                                                                                l)amino)phenyl)
                                                                                acetamide, potassium salt.
2217-767.............................            2217  Mefluidide 2-S Concentrate..  Mefluidide, diethanolamine
                                                                                salt.
2217-768.............................            2217  Embark E-Z-TU-USE Plant       Mefluidide, diethanolamine
                                                        Grown Regulator.              salt.
2217-802.............................            2217  EH 1135 PGR.................  Imazethapyr, ammonium salt;
                                                                                Imazapyr & Mefluidide,
                                                                                diethanolamine salt.
55146-81.............................           55146  Flouronil Fungicide.........  Chlorothalonil & Metalaxyl-
                                                                                M.
65331-6..............................           65331  Amitraz Technical...........  Amitraz.
66222-135............................           66222  Thidiazuron 50 WSB..........  Thidiazuron.
66330-24.............................           66330  Captan 4 Flowable...........  Captan.
66330-26.............................           66330  Captan 50 WP................  Captan.
66330-27.............................           66330  Captan Garden Spray.........  Captan.
66330-209............................           66330  Captan 80W..................  Captan.
66330-235............................           66330  Captan 4 Flowable...........  Captan.
66330-238............................           66330  Captan 4 Flowable Seed        Captan.
                                                        Protectant.
66330-239............................           66330  Captec 4L Captan Flowable     Captan.
                                                        Fungicide.
66330-242............................           66330  Mepiquat Chloride Liquid      Mepiquat chloride.
                                                        Concentrate.
66330-243............................           66330  Mepichlor Pill..............  Mepiquat chloride.
66330-280............................           66330  Mepplus Concentrate.........  Mepiquat chloride &
                                                                                Bacillus cereus strain
                                                                                BP01.
66330-285............................           66330  Mepplus Pill................  Mepiquat chloride &
                                                                                Bacillus cereus strain
                                                                                BP01.
66330-346............................           66330  Pix Concentrate Plant         Mepiquat chloride.
                                                        Regulator.
66330-348............................           66330  MC-6........................  Mepiquat chloride.
66330-393............................           66330  ARY 0494-006................  Bacillus cereus strain BP01
                                                                                & Mepiquat chloride.
CO-080004............................             400  Enhance.....................  Captan & Carboxin.
CO-090006............................            5481  Orthene Turf, Tree &          Acephate.
                                                        Ornamental WSP.
FL-050004............................           70506  Surflan as Specialty          Oryzalin.
                                                        Herbicide.
ME-160002............................           71512  Omega 500F..................  Fluazinam.
OR-040033............................           10163  Onager 1E...................  Hexythiazox.
OR-120018............................           59639  Valor Herbicide.............  Flumioxazin.
WA-040021............................             228  Riverdale Aquaneat Aquatic    Glyphosate-
                                                        Herbicide.                    isopropylammonium.
WI-130001............................             100  Dual Magnum Herbicide.......  S-Metolachlor.
WY-070002............................           56228  DRC-1339 Concentrate Staging  Starlicide.
                                                        Label.
----------------------------------------------------------------------------------------------------------------

                           Table 2--Product Registration Amendments To Terminate Uses
----------------------------------------------------------------------------------------------------------------
                                                                                Uses to be
       Registration No.           Company No.       Product name       Active ingredients        terminated
----------------------------------------------------------------------------------------------------------------
11678-55......................           11678  Magnate Technical...  Imazalil............  Seed treatment uses.
43813-4.......................           43813  Fungaflor 75 SP.....  Imazalil sulphate...  Seed treatment uses.
66222-1.......................           66222  Captan 50-WP........  Captan..............  Turf.
66330-209.....................           66330  Captan 80W..........  Captan..............  Turf.
66330-234.....................           66330  Captan 50 Wettable    Captan..............  Turf.
                                                 Powder.
66330-239.....................           66330  Captec 4L Captan      Captan..............  Turf.
                                                 Flowable Fungicide.
----------------------------------------------------------------------------------------------------------------

    Table 3 of this unit includes the names and addresses of record for
all registrants of the products in Tables 1 and 2 of this unit, in
sequence by EPA company number. This number corresponds to the first
part of the EPA registration numbers of the products listed above.

         Table 3--Registrants of Cancelled and Amended Products
------------------------------------------------------------------------
     EPA company No.                 Company name and address
------------------------------------------------------------------------
100.....................  Syngenta Crop Protection, LLC, 410 Swing Road,
                           P.O. Box 18300, Greensboro, NC 27419-8300.
228.....................  Nufarm Americas, Inc., 4020 Aerial Center
                           Pkwy., Ste. 101, Morrisville, NC 27560.
352.....................  E. I. Du Pont De Nemours and Company, Attn:
                           Manager, US Registration, DuPont Crop
                           Protection, Chestnut Run Plaza (CRP 720/2E5),
                           974 Centre Rd., Wilmington, DE 19805.
400.....................  MacDermid Agricultural Solutions, Inc. C/O
                           Arysta LifeScience North America, LLC, 15401
                           Weston Parkway, Suite 150, Cary, NC 27513.
432.....................  Bayer Environmental Science, A Division of
                           Bayer CropScience, LP 2 T. W. Alexander
                           Drive, Research Triangle Park, NC 27709.
499.....................  BASF Corporation, 26 Davis Drive, P.O. Box
                           13528, Research Triangle Park, NC 27709-3528.
1381....................  Winfield Solutions, LLC, P.O. Box 64589, St.
                           Paul, MN 55164-0589.
2217....................  PBI/Gordon Corp., 1217 West 12th Street, P.O.
                           Box 014090, Kansas City, MO 64101-0090.
5481....................  AMVAC Chemical Corporation, 4695 MacArthur
                           Court, Suite 1200, Newport Beach, CA 92660-
                           1706.
10163...................  Gowan Company, P.O. Box 5569, Yuma, AZ 85366.
11678...................  ADAMA Makhteshim LTD., Agent Name: Makhteshim-
                           Agan of North America, Inc., D/B/A ADAMA 3120
                           Highwoods Blvd., Suite 100, Raleigh, NC
                           27604.
43813...................  Janssen PMP, A Division of Janssen
                           Pharmaceutica NV 1125 Trenton-Harbourton Rd.,
                           Titusville, NJ 08560-0200.
55146...................  Nufarm Americas, Inc., AGT Division, 4020
                           Aerial Center Pkwy., Suite 101, Morrisville,
                           NC 27560.
56228...................  U.S. Department of Agriculture, Animal and
                           Plant Health Inspection Service, 4700 River
                           Road, Unit 149, Riverdale, MD 20737.
59639...................  Valent U.S.A. LLC, 1600 Riviera Avenue, Suite
                           200, Walnut Creek, CA 94596-8025.
65331...................  Merial, Inc., 3239 Satellite Blvd., Duluth, GA
                           30096.
66222...................  Makhteshim Agan of North America, Inc., D/B/A
                           Adama, 3120 Highwoods Blvd., Suite 100,
                           Raleigh, NC 27604.
66330...................  Arysta LifeScience North America, LLC, 15401
                           Weston Parkway, Suite 150, Cary, NC 27513.
70506...................  United Phosphorus, Inc. 630 Freedom Business
                           Center, Suite 402, King of Prussia, PA 19406.
71512...................  ISK Biosciences Corporation, 7470 Auburn Road,
                           Suite A, Concord, OH 44077.
------------------------------------------------------------------------

III. Summary of Public Comments Received and Agency Response to
Comments

    During the public comment period provided, EPA received no comments
in response to the October 17, 2018 Federal Register notice announcing
the Agency's receipt of the requests for voluntary cancellations and
amendments to terminate uses of products listed in Tables 1 and 2 of
Unit II.

IV. Cancellation Order

    Pursuant to FIFRA section 6(f) (7 U.S.C. 136d(f)(1)), EPA hereby
approves the requested cancellations and amendments to terminate uses
of the registrations identified in Tables 1 and 2 of Unit II.
Accordingly, the Agency hereby orders that the product registrations
identified in Tables 1 and 2 of Unit II are canceled and amended to
terminate the affected uses. The effective date of the cancellations
that are subject of this notice is February 14, 2019. Any distribution,
sale, or use of existing stocks of the products identified in Tables 1
and 2 of Unit II in a manner inconsistent with any of the provisions
for disposition of existing stocks set forth in Unit VI will be a
violation of FIFRA.

V. What is the agency's authority for taking this action?

    Section 6(f)(1) of FIFRA (7 U.S.C. 136d(f)(1)) provides that a
registrant of a pesticide product may at any time request that any of
its pesticide registrations be canceled or amended to terminate one or
more uses. FIFRA further provides that, before acting on the request,
EPA must publish a notice of receipt of any such request in the Federal
Register. Thereafter, following the public comment period, the EPA
Administrator may approve such a request. The notice of receipt for
this action was published for comment in the Federal Register of
October 17, 2018 (83 FR 52444) (FRL-9983-91). The comment period closed
on November 16, 2018.

VI. Provisions for Disposition of Existing Stocks

    Existing stocks are those stocks of registered pesticide products
which are currently in the United States and which were packaged,
labeled, and released for shipment prior to the effective date of the
action. The existing stocks provision for the products subject to this
order is as follows.
    For voluntary cancellations, the registrants may continue to sell
and distribute existing stocks of products listed in Table 1 until
February 14, 2020, which is 1 year after publication

of this cancellation order in the Federal Register. Thereafter, the
registrants are prohibited from selling or distributing products listed
in Table 1 of Unit II, except for export in accordance with FIFRA
section 17 (7 U.S.C. 136o) or for proper disposal.
    Now that EPA has approved product labels reflecting the requested
amendments to terminate uses, registrants are permitted to sell or
distribute products listed in Table 2 of Unit II under the previously
approved labeling until August 14, 2020, a period of 18 months after
publication of the cancellation order in this Federal Register, unless
other restrictions have been imposed. Thereafter, registrants will be
prohibited from selling or distributing the products whose labels
include the terminated uses identified in Table 2 of Unit II, except
for export consistent with FIFRA section 17 or for proper disposal.
    Persons other than the registrant may sell, distribute, or use
existing stocks of canceled products and products whose labels include
the terminated uses until supplies are exhausted, provided that such
sale, distribution, or use is consistent with the terms of the
previously approved labeling on, or that accompanied, the canceled
products and terminated uses.

    Authority:  7 U.S.C. 136 et seq.

    Dated: December 18, 2018.
Delores Barber,
Director, Information Technology and Resources Management Division,
Office of Pesticide Programs.
[FR Doc. 2019-02385 Filed 2-13-19; 8:45 am]
 BILLING CODE 6560-50-P


[Federal Register Volume 79, Number 148 (Friday, August 1, 2014)]
[Notices]
[Page 44818]
[FR Doc No: 2014-18258]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Docket ID: FEMA-2014-0008; OMB No. 1660-0129]

Agency Information Collection Activities: Submission for OMB
Review; Comment Request, Federal Emergency Management Agency Individual
Assistance Survivor Centric Customer Satisfaction Surveys (Formerly,
Follow-Up Program Effectiveness & Recovery Survey)

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Federal Emergency Management Agency (FEMA) will submit the
information collection abstracted below to the Office of Management and
Budget for review and clearance in accordance with the requirements of
the Paperwork Reduction Act of 1995. The submission will describe the
nature of the information collection, the categories of respondents,
the estimated burden (i.e., the time, effort and resources used by
respondents to respond) and cost, and the actual data collection
instruments FEMA will use.

DATES: Comments must be submitted on or before September 2, 2014.

ADDRESSES: Submit written comments on the proposed information
collection to the Office of Information and Regulatory Affairs, Office
of Management and Budget. Comments should be addressed to the Desk
Officer for the Department of Homeland Security, Federal Emergency
Management Agency, and sent via electronic mail to
<EMAIL_ADDRESS>or faxed to<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Requests for additional information or
copies of the information collection should be made to Director,
Records Management Division, 500 C Street SW., Washington, DC 20472,
facsimile number<PHONE_NUMBER>, or email address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

Changes Since Publication of the 60 Day Federal Register Notice for the
Federal Emergency Management Agency Individual Assistance Survivor
Centric Customer Satisfaction Surveys (Formerly, Follow-Up Program
Effectiveness & Recovery Survey

    The number of respondents and the estimated burden hours have
increased since FEMA published the the 60 day Federal Register Notice
on February 28, 2014. See 79 FR 11456. This is due to an increase in
the number of times the surveys are conducted from quarterly to
approximately six times per year, the addition of focus groups, and
additional questions covering survey topics whose answers will provide
timely customer satisfaction results and benefit the divisions and
offices managing FEMA's Individual Assistance programs. The respondent
burden increased from 1,536 to 2,832, for an increase of 1,296
respondents. The burden hours increased from 307 to 1,545, for an
increase of 1,238 hours. The annual cost has incrased from $0.00 to
$8,604 for travel to focus groups.

Collection of Information

    Title: Federal Emergency Management Agency Individual Assistance
Survivor Centric Customer Satisfaction Surveys (formerly, Follow-Up
Program Effectiveness & Recovery Survey).
    Type of information collection: Revision of a currently approved
collection.
    Form Titles and Numbers: FEMA Form 007-0-14, and Federal Emergency
Management Agency Individual Assistance Survivor Centric Customer
Satisfaction Surveys.
    Abstract: Federal agencies are required to survey their customers
to determine the kind and quality of services customers want and their
level of satisfaction with those services. FEMA managers use the survey
results to measure performance against standards for performance and
customer service, measure achievement of strategic planning objectives,
and generally gauge and make improvements to disaster service that
increase customer satisfaction.
    Affected Public: Individuals and Households.
    Estimated Number of Respondents: 2,832.
    Estimated Total Annual Burden Hours: 1,545.
    Estimated Cost: $8,604.00.

    Dated: July 17, 2014
Charlene D. Myrthil,
Director, Records Management Division, Mission Support Bureau, Federal
Emergency Management Agency, Department of Homeland Security.
[FR Doc. 2014-18258 Filed 7-31-14; 8:45 am]
BILLING CODE 9111-23-P


[Federal Register Volume 76, Number 152 (Monday, August 8, 2011)]
[Notices]
[Pages 48167-48168]
[FR Doc No: 2011-19955]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0508]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Blood Establishment Registration and Product Listing,
Form FDA 2830

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on the information collection
requirements relating to the blood establishment registration and
product listing requirements in the Agency's regulations and Form FDA
2830.

DATES: Submit either electronic or written comments on the collection
of information by October 7, 2011.

ADDRESSES: Submit electronic comments on the collection of information
to http://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Juanmanuel Vilela, Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Blood Establishment Registration and Product Listing, Form FDA 2830--21
CFR Part 607--(OMB Control Number 0910-0052)--Extension

    Under section 510 of the Federal Food, Drug, and Cosmetic Act (21
U.S.C. 360), any person owning or operating an establishment that
manufactures, prepares, propagates, compounds, or processes a drug or
device must register with the Secretary of Health and Human Services,
on or before December 31 of each year, his or her name, place of
business, and all such establishments, and must submit, among other

information, a listing of all drug or device products manufactured,
prepared, propagated, compounded, or processed by him or her for
commercial distribution. In part 607 (21 CFR part 607), FDA has issued
regulations implementing these requirements for manufacturers of human
blood and blood products.
    Section 607.20(a), in brief, requires owners or operators of
certain establishments that engage in the manufacture of blood products
to register and to submit a list of every blood product in commercial
distribution. Section 607.21, in brief, requires the owners or
operators of establishments entering into the manufacturing of blood
products to register within 5 days after beginning such operation and
to submit a list of every blood product in commercial distribution at
the time. If the owner or operator of the establishment has not
previously entered into such operation for which a license is required,
registration must follow within 5 days after the submission of a
biologics license application. In addition, owners or operators of all
establishments so engaged must register annually between November 15
and December 31 and must update their blood product listing information
every June and December. Section 607.22 requires the use of Form FDA
2830 (Blood Establishment Registration and Product Listing) for initial
registration, subsequent annual registration, and for blood product
listing information. Section 607.25 sets forth the information required
for establishment registration and blood product listing. Section
607.26, in brief, requires certain changes to be submitted on Form FDA
2830 as an amendment to establishment registration within 5 days of
such changes. Section 607.30(a), in brief, sets forth the information
required from owners or operators of establishments when updating their
blood product listing information every June and December, or at the
discretion of the registrant at the time the change occurs. Section
607.31 requires that additional blood product listing information be
provided upon FDA request. Section 607.40, in brief, requires certain
foreign blood product establishments to comply with the establishment
registration and blood product listing information requirements
discussed above and to provide the name and address of the
establishment and the name of the individual responsible for submitting
establishment registration and blood product listing information as
well as the name, address, and phone number of its U.S. agent.
    Among other uses, this information assists FDA in its inspections
of facilities, and its collection is essential to the overall
regulatory scheme designed to ensure the safety of the nation's blood
supply. Form FDA 2830 is used to collect this information.
    Respondents to this collection of information are human blood and
plasma donor centers, blood banks, certain transfusion services, other
blood product manufacturers, and independent laboratories that engage
in quality control and testing for registered blood product
establishments.
    FDA estimates the burden of this collection of information based
upon information obtained from FDA's Center for Biologics Evaluation
and Research's database and FDA experience with the blood establishment
registration and product listing requirements.
    FDA estimates the burden of this collection of information as
follows:

                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                               Number of                  Average
                                                  Number of    responses      Total      burden per
        21 CFR Section           Form FDA 2830   respondents      per         annual      response   Total hours
                                                               respondent   responses    (in hours)
----------------------------------------------------------------------------------------------------------------
607.20(a), 607.21, 607.22,     Initial                    49            1           49         1              49
 607.25, and 607.40.            Registration.
607.21, 607.22, 607.25,        Re-registration.        2,589            1        2,589         0.5         1,294
 607.26, 607.31, and 607.40.
607.21, 607.25, 607.30(a),     Product Listing           180            1          180         0.25           45
 607.31, and 607.40.            Update.
                                                ----------------------------------------------------------------
    Total....................  ................  ...........  ...........  ...........  ...........        1,388
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    Dated: July 26, 2011.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2011-19955 Filed 8-5-11; 8:45 am]
BILLING CODE 4160-01-P